Zyversa Therapeutics, Inc.

Biotechnology • Healthcare • Weston, FL, United States • ZVSA (OQB)

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Why ZyVersa Therapeutics, Inc. (ZVSA) Went Down On Thursday? - Yahoo Finance

Yahoo Finance • Apr 10

ZyVersa Therapeutics to be delisted from Nasdaq, trading to move to OTC market - Investing.com

Investing.com • Jul 16

ZyVersa Therapeutics Reports Second Quarter 2025 Financial - GlobeNewswire

GlobeNewswire • Aug 13

ZyVersa Therapeutics, Inc. Provides Pipeline and Financial Update: Advances in Clinical Trials for VAR 200 and IC 100 - Nasdaq

Nasdaq • May 12

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? - Sahm

Sahm • Jul 8

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ZyVersa Therapeutics, Inc. had layoffs?

No layoff events have been recorded for ZyVersa Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does ZyVersa Therapeutics, Inc. have?

ZyVersa Therapeutics, Inc. has approximately 7 employees.

What industry is ZyVersa Therapeutics, Inc. in?

ZyVersa Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is ZyVersa Therapeutics, Inc. a publicly traded company?

Yes, ZyVersa Therapeutics, Inc. is publicly traded under the ticker symbol ZVSA on the OQB. The company has a market capitalization of approximately $0.00 billion.

Where is ZyVersa Therapeutics, Inc. headquartered?

ZyVersa Therapeutics, Inc. is headquartered in Weston, FL, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.